Eskiin
Send these marketing claims to the shower.
XanRelax and Addall
Case Name (Date)
Brown et al. v. ZMB Enterprises LLC
22-cv-54, S.D. Cal.
(Jan. 2022)
Product/Service
XanRelax and Addall
Allegations
Misleadingly labeling products as “dietary supplements” when they contain illegal ingredients and thus do not meet the definition of “dietary supplement” under federal law
Misleadingly using the name XanRelax to make consumers believe the product provides benefits similar to the prescription drug Xanax
Misleadingly using the name Addall to make consumers believe the product provides benefits similar to the prescription drug Adderall
Falsely marketing products as able to treat, cure, and prevent diseases, including depression, anxiety, and ADHD, and without FDA approval to do so
Status
Pending
The Latest
TINA.org Tells DOT: Don’t Muddy Airline Pricing
A proposed rule change could make it harder to know what you’ll actually pay for a flight.
Carhartt: Making Football Possible
Carhartt honors the dedicated individuals who make football possible.
Tinggly
TINA.org unwraps the hidden cost of these gift boxes.
Alani Nu Facing Increased Scrutiny over Marketing to Kids
Following lawsuit, Texas AG launches probe into energy drink’s “youth-oriented branding strategies.”